Shu Wen Li
Direttore/Membro del Consiglio presso Impax Laboratories (Taiwan), Inc.
Posizioni attive di Shu Wen Li
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Impax Laboratories (Taiwan), Inc.
 Impax Laboratories (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Impax Laboratories (Taiwan), Inc. engages in the research, development and manufacturing of oral controlled-release dosage forms of generic drugs. It also involves in the formulation and clinical development of alternate dosage forms of drugs for diseases in the central nervous system. Its products include branded pharmaceutical product such as IPX066 and generic pharmaceutical products such as Acarbose, Dantrolene Sodium, and Fenofibrate tablets. The company was founded on May 4, 2007 and is headquartered in Miaoli, Taiwan. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Shu Wen Li
Statistiche
Distribuzione geografica
| Taiwan | 2 |
Posizioni
| Director/Board Member | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Impax Laboratories (Taiwan), Inc.
Impax Laboratories (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Impax Laboratories (Taiwan), Inc. engages in the research, development and manufacturing of oral controlled-release dosage forms of generic drugs. It also involves in the formulation and clinical development of alternate dosage forms of drugs for diseases in the central nervous system. Its products include branded pharmaceutical product such as IPX066 and generic pharmaceutical products such as Acarbose, Dantrolene Sodium, and Fenofibrate tablets. The company was founded on May 4, 2007 and is headquartered in Miaoli, Taiwan. | Health Technology |
- Borsa valori
- Insiders
- Shu Wen Li
- Esperienza
